Overview

Exploring Learning and Unlearning of Fear

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The present study investigates the effect of d-cycloserine on learning and unlearning of fear in healthy humans and its underlying effect on the amygdala. As a second objective, the effect of genotype on fear learning will be studied.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Treatments:
Cycloserine
Criteria
Inclusion Criteria:

- No axis I diagnosis compatible with the DSM-IV by means of a structured diagnostic
interview

- Right-handed

Exclusion Criteria:

- Current psychopharmacological or psychological treatment.

- The presence of a physical/medical condition that may interfere with the study.

- A contraindication for the use of DCS

- Pacemaker, medication pump (such as insulin pump), hearing aid, removable
prosthodontics

- Metal in or on body (such as acupuncture needles, artificial limbs, stents, metal
splints, clips, implanted electrodes, tattoos, or piercings)